A Phase II/III Study of Immunotherapy with Nivolumab, Ipilimumab, and GM-CSF in Patients with Advanced Melanoma
Source: Memorial Sloan Kettering Cancer Center
Nivolumab and ipilimumab are immunotherapy drugs used to treat advanced melanoma. They can be used individually or together.
In this study, researchers are assessing the safety and effectiveness of combining nivolumab and ipilimumab immunotherapy with another drug used in cancer care called GM-CSF (sargramostim) in patients with advanced melanoma.
GM-CSF signals the body to make more white blood cells.
